These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 19309547)
1. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547 [TBL] [Abstract][Full Text] [Related]
2. Role of Chlamydia pneumoniae in atherosclerosis. Watson C; Alp NJ Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368 [TBL] [Abstract][Full Text] [Related]
3. Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review. Vainas T; Sayed S; Bruggeman CA; Stassen FR Drugs Today (Barc); 2009 Nov; 45 Suppl B():165-72. PubMed ID: 20011710 [TBL] [Abstract][Full Text] [Related]
4. Chlamydia pneumoniae and vascular disease: an update. Mussa FF; Chai H; Wang X; Yao Q; Lumsden AB; Chen C J Vasc Surg; 2006 Jun; 43(6):1301-7. PubMed ID: 16765261 [TBL] [Abstract][Full Text] [Related]
5. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials. Higgins JP Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585 [TBL] [Abstract][Full Text] [Related]
6. Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials. Campbell LA; Rosenfeld ME Front Cell Infect Microbiol; 2014; 4():34. PubMed ID: 24711989 [No Abstract] [Full Text] [Related]
7. Chlamydia pneumoniae and atherosclerosis. Campbell LA; Kuo CC Semin Respir Infect; 2003 Mar; 18(1):48-54. PubMed ID: 12652454 [TBL] [Abstract][Full Text] [Related]
8. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Stassen FR; Vainas T; Bruggeman CA Pharmacol Rep; 2008; 60(1):85-92. PubMed ID: 18276989 [TBL] [Abstract][Full Text] [Related]
12. Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview. Di Pietro M; Filardo S; De Santis F; Sessa R Int J Mol Sci; 2013 Jul; 14(7):15105-20. PubMed ID: 23877837 [TBL] [Abstract][Full Text] [Related]
13. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease. Dugan JP; Feuge RR; Burgess DS Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941 [TBL] [Abstract][Full Text] [Related]
15. Is Chlamydia pneumoniae a risk factor for peripheral atherosclerosis? Ustünsoy H; Sivrikoz C; Sirmatel F; Bakir K; Burma O; Kazaz H Asian Cardiovasc Thorac Ann; 2007 Jan; 15(1):9-13. PubMed ID: 17244915 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic therapy for coronary heart disease: the myth and the reality. Kuppuswamy VC; Gupta S Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482 [TBL] [Abstract][Full Text] [Related]
17. Infections caused by Chlamydophila pneumoniae. Choroszy-Król I; Frej-Mądrzak M; Hober M; Sarowska J; Jama-Kmiecik A Adv Clin Exp Med; 2014; 23(1):123-6. PubMed ID: 24596014 [TBL] [Abstract][Full Text] [Related]
18. [Chlamydia pneumoniae, atherosclerosis, and coronary disease]. Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076 [TBL] [Abstract][Full Text] [Related]
19. Chlamydia pneumoniae and atherosclerosis: the role of mast cells. Di Pietro M; Schiavoni G; Del Piano M; Shaik Y; Boscolo P; Caraffa A; Grano M; Teté S; Conti F; Sessa R J Biol Regul Homeost Agents; 2009; 23(2):65-9. PubMed ID: 19589286 [TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role? Mahony JB; Coombes BK FEMS Microbiol Lett; 2001 Apr; 197(1):1-9. PubMed ID: 11287138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]